Alzheimer's Society says it’s alarming that nearly two thirds of care workers have not received any dementia training, and a long-term social care workforce strategy is needed.

Alzheimer’s Society is continuing work on the Blood Biomarker Challenge, a project that could bring dementia blood tests to the NHS within five years.

Alzheimer's Society responds to the Autumn Budget announcement of £600 million in social care funding and what this might mean for people affected by dementia.

Tim Baverstock, Head of Local Systems Influencing at Alzheimer’s Society, welcomes the development of the CQC’s dementia strategy. The State of Care report shows that dementia cannot, and must not, be ignored.

The MHRA have approved donanemab for the treatment of Alzheimer’s disease. However, NICE does not recommend use on the NHS for any patients.

Dr Richard Oakley, our Director of Research and Innovation, explains why Alzheimer's Society is proud to work with Our Future Health, one of the biggest health research programmes in the UK.